ONE STOP SHOPfor over 1,000 Life Science Research Reports spanning over 50 Research AreasJust some of the Reports Available Include:

• Alzheimer’s Disease• Biomarkers & Diagnostics• BioPharma Strategy• Biosimilars & Generic Markets• Cancer Research and Therapeutics• Chemistry• Clinical Trials & Translational

Medicine• Data Mining• Drug Discovery & Development• Health IT

• Infectious Disease• Medical Devices• Multiple Sclerosis• Ocular Therapeutics• Pain Management• Pharmaceutical Marketing• Sequencing• Vaccines

...and many others

AFFILIATED REPORTSCOLLECTION

InsightPharmaReports.com

InsightPharmaReports.com

An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues

Driving R&D Productivity ….

Insight Pharma Reports has been a report leader for over 15 years, and continues to deliver high quality data and

findings. Our reports offer a comprehensive analysis of the drug discovery and development market, offering over

50 topic areas of research reports. All propriety reports that Insight Pharma Reports publishes are complete with

in-depth interviews with senior level research executives and include extensive survey data. On average each

report has insights from over 100 topic experts.

Also, available through Insight Pharma Reports and our network of Affiliated Reports, we offer over 1000 scientific

research reports, with new reports being added weekly. However, if you can’t find a topic on what you are looking

for, contact us, we can help you find a relevant report that fits your needs from our network of report publishers.

Contact Us:Academic, Government and Non-Profit Discounts are available on most reports. We offer multi-report discounts as well. For more information on discounts and up-to-date pricing, contact Kerri Simpson at: ksimpson@InsightPharmaReports.com or call (781) 972-1347

InsightPharmaReports.com 3

Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management

This report explores the background, history and basic research of liquid biopsy covering the three sample categories that dominate liquid biopsy today: circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (EVs, also known as exosomes). This report also details the commercial aspects, market dynamics, and trends of liquid biopsy.

Report PricingAcademic/GVT Single User - $1,595.00

Single User - $2,495.00Single Site - $3,995.00Multi Site - $9,950.00

InsightPharmaReports.com/liquid-biopsy-report

Marketing to Life Scientists: A Best Practice Guide for Marketers

Over 500 active life scientists across Biotech, Pharma, Academic, Healthcare, Hospital, Government and CRO industries answer questions and provide insight to marketers. The report is laid out with commentary, analysis and striking visuals divided into key categories, including: Technology and Mobile, Outbound Marketing, Email Marketing, Telemarketing, Direct Mail Marketing, Social Media, Content Marketing, Advertising Mediums, Tradeshows and Other Media.

Report PricingSingle User - $995.00

Single Site - $1,995.00Multi Site - $2,995.00

InsightPharmaReports.com/marketing-to-life-scientists-guide

The Human Microbiome: Biomedical Implications and Birth of a Market

This report covers the evolution of microbiome research and its growth in the commercial market. Specific areas of study include microbial ecology, systems biology, diet, diagnostics, contributions in health and disease, and infectious disease.

Report Pricing:Academic/GVT Single User - $1,595.00

Single User - $2,495.00 Single Site - $3,995.00 Multi Site - $9,950.00

InsightPharmaReports.com/human-microbiome-report

Cancer Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. It will cover the following principle therapies; checkpoint inhibitors, anticancer vaccines, and adoptive cellular immunotherapy.

Report Pricing:Academic/GVT Single User - $1,595.00

Single User - $2,495.00 Single Site - $3,995.00 Multi Site - $9,950.00

InsightPharmaReports.com/cancer-immunotherapy-report

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders

Including substantial background information, illustrated with graphics and figures, this report captures market growth of biomarkers, advantages, disadvantages, and validation techniques.

Report Pricing:Academic/GVT Single User - $1,595.00

Single User - $2,495.00 Single Site - $3,995.00 Multi Site - $9,950.00

InsightPharmaReports.com/neurobiomarkers-and-diagnostics/report

Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria

This report covers evolutionary growth of antibiotic resistant bacteria with a focus in research aspects, commercial aspects, market aspects, and trends in antibiotic resistance.

Report Pricing: Academic/GVT Single User - $1,595.00

Single User - $2,495.00 Single Site - $3,995.00 Multi Site - $9,950.00

InsightPharmaReports.com/drug-resistant-bacteria/

InsightPharmaReports.com 4

Vaccines: The End of Illness

This report focuses on the most recent vaccine research, emphasizing their reputation as an unmatched tool of efficient healthcare. Their low cost, extended protection and the impossibility of their circumvention through development of resistance on the part of the target pathogen have been longstanding attributes of vaccines. Today, vaccine technology is undergoing a fundamental revolution, taking advantage of the profound understanding of the immune system and its ability to mount protective antibody production and cell-based responses to foreign antigens. Understanding these properties will not only enable the development of innovative diagnostics but also the advancement of therapeutic applications.

Report Pricing:Academic/GVT Single User - $1,595.00

Single User - $2,495.00 Single Site - $3,995.00 Multi Site - $9,950.00

InsightPharmaReports.com/vaccines-endofillness

MicroRNA: An Insight to miRNA-based Microarrays, Diagnostics and Therapeutics

This report covers the specifics of microRNA (miRNA) as it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA’s non-coding nature and ability to affect genetic expression make it a novel candidate for use as a biomarker for a variety of diseases. This prompted the pursuit of miRNA-based microarrays and diagnostics for the advancement in therapeutic development. Furthermore there are a number of academic laboratories not only validating miRNAs, but also identifying them in a number of diseases and examining their molecular actions in the presence of other molecules.

Report Pricing: Academic/GVT Single User - $1,595.00

Single User - $2,495.00 Single Site - $3,995.00 Multi Site - $9,950.00

InsightPharmaReports.com/mirna-dxrx

Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks

This report delves into the rapidly evolving field of digital pathology, briefly reviewing the underlying scientific and technological concepts and providing an insightful perspective on various factors thought to be of significance to the development and future of this space.

Report Pricing: Academic/GVT Single User - $1,595.00

Single User - $2,495.00 Single Site - $3,995.00 Multi Site - $9,950.00

InsightPharmaReports.com/digitalpathology

Molecular Diagnostics: An Insight to Rising Markets and Trends in Cancer and Prenatal Technologies

This report covers market research, relevant disease background, and a number of rising technologies available to physicians and clinicians in the cancer and prenatal space. Cancer is one of the leading causes of death, and therefore a popular area of study for screening and diagnostic assays. Another area of interest is in genetic information and prenatal diagnostic assays, specifically noninvasive assays. Covered within both these sections are disease backgrounds including incidence, risk, symptoms and early detection, and therapeutic options.

Report Pricing:Academic/GVT Single User - $1,595.00

Single User - $2,495.00Single Site - $3,995.00Multi Site - $9,950.00

InsightPharmaReports.com/Molecular-Diagnostic-Market-and-Testing

Ocular Disorders: Rising Therapeutics, Technologies, and Devices

This report covers a handful of companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while alsoproviding alternative therapeutic options for various ocular complications. In an interview with several companies including Oraya Therapeutics, VisionCare Ophthalmic Technologies, Omeros, and Kala Pharmaceuticals, representatives mentioned several technologies and devices in development to improve the current line of therapeutics.

Report Pricing:Academic/GVT Single User - $1,095.00

Single User - $1,995.00Single Site - $3,495.00Multi Site - $9,550.00

InsightPharmaReports.com/ocular-disorders

InsightPharmaReports.com 5

With an academic institution, government agency, at a non-profit or a start-up? Looking for a corporate or site license? Want to order multiple reports? Can’t find a report you are looking for?

Contact Kerri Simpson at 781-972-1347 or ksimpson@InsightPharmaReports.com

Prenatal Diagnostics: Invasive Testing, Noninvasive Testing, and Rising Maternal Screening Methods for Preeclampsia and Preterm LaborThis report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare. Although covering standard invasive procedure, this report focuses on the noninvasive technologies either on the market or in development.

Report Pricing:Academic/GVT Single User - $1,595.00

Single User - $2,495.00Single Site - $3,995.00Multi Site - $9,950.00

InsightPharmaReports.com/Prenatal-Diagnostic-Testing

Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective

This report covers several technologies, epigenetic targets, and market outlook. The first part of this report covers necessary background information, mostly pertaining to epigenetic targets, and the reasons they are being investigated. Several companies have kindly disclosed several strategies, methods, and techniques that they use for either target identification or technology development.

Report Pricing:Academic/GVT Single User - $1,595.00

Single User - $2,495.00Single Site - $3,995.00Multi Site - $9,950.00

InsightPharmaReports.com/Epigenetics-Report

Macrocycles: Discovery, Development & Technologies

This report covers several areas of novel compound including current use in pharmaceutical companies and rising technologies in biotechnology companies. This report covers background material including a more in depth analysis of what macrocycles are and the pharmacokinetic properties (absorption, distribution, metabolism, and excretion) they exhibit. Challenges, benefits, and additional properties that are considered with their development as drugs are covered as well.

Report Pricing:Academic/GVT Single User - $1,595.00

Single User - $2,495.00Single Site - $3,995.00Multi Site - $9,950.00

InsightPharmaReports.com/Macrocycles

Molecular Biomarkers for Cancer Detection and ManagementThis report focuses on recent progress and new directions in this highly dynamic diagnostic field. Covering extensive background and history, commercialization, and marketing trends of cancer biomarker technologies, this report provides heavy detail of historical and evolutionary aspects of cancer biomarkers, delineating some of the difficulties researchers face in validating and commercializing their candidate assays.

Report Pricing:Single User - $2,495.00Single Site - $3,995.00Multi Site - $9,950.00

InsightPharmaReports.com/Molecular-Biomarkers-for-Cancer-Detection-Management

InsightPharmaReports.com 6

Other titles available through our Affiliated Reports Collections include:

• Antibody-Drug Conjugates 2014 - A Business, Technology & Pipeline Analysis

• Auto Inflammatory Disease Pipeline Review

• Biobanks-2012 Yearbook

• Bioinformatics Partnering Terms & Agreements

• Biomarker Partnering Terms & Agreements

• Cancer Vaccine Partnering Agreements

• Companion Diagnostics Partnering Terms and Agreements

• Competitor Analysis: Antibody-Drug Conjugates

• Competitor Analysis: Coagulation Factors

• Co-promotion and Co-marketing Partnering Terms and Agreements

• Diagnostics Partnering Terms and Agreements

• Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

• Drug Delivery Partnering Terms and Agreements

• Endpoints - Clinical Trials in Respiratory Diseases

• Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

• Ensuring Optimal Medical Affairs Performance

• EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022

• Fatty Liver Disease - Pipeline Review

• Gene Therapy Partnering Terms and Agreements

• Influence of Antibody Attributes on Clinical Success - A Technology and Corporate Benchmark Analysis

• Immunology Partnering Terms and Agreements

• Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs’ Major Market Share

• Liver Cancer - Pipeline Review

• Liver Failure - Pipeline Review

• Mammography Equipment Market to 2019

• MediPoint: Breast Cancer Imaging - Global Analysis and Market Forecasts

• MediPoint: Cardiac Rhythm Management - US Analysis and Market Forecasts

• Monoclonal Antibodies Market in Breast Cancer to 2019

• Multiple Sclerosis Therapeutics to 2019

• New Product Penetration: Understanding & Accelerating New Product Uptake

• Pain Management Therapeutics Market to 2019

• PharmaFocus: Biomarkers in Alzheimer’s Disease

• Personalized Medicine Partnering Terms and Agreements

• Pharmaceuticals Monthly Deals Analysis: Partnerships, Licensing, Investments and M&A Trends

• Therapy Trends: Multiple Sclerosis

• Vaccine Partnering Terms and Agreements

For a full listing of our Affiliated Reports Collection, visit: InsightPharmaReports.com

InsightPharmaReports.com 7

Bundle Packages:

New this year, Insight Pharma Reports are offering a series of bundled report packages.

Antibody and Protein Reports Bundle - $2995 • The New Generation of Antibody Therapeutics• Engineering Next-Generation Therapeutic Proteins• Monoclonal Antibodies in the Pipeline: A Segment of Major Growth Report

Biomarker, Diagnostics and Personalized Medicine Reports Bundle - $3995 • Molecular Biomarkers for Cancer Detection and Management• Companion Diagnostics and Other Aspects of Personalized Medicine• Commercializing Biomarkers in Therapeutic and Diagnostic Applications• Molecular Diagnostics: Double-Digit Growth Anticipated

Cancer Reports Bundle - $4499 • Molecular Biomarkers for Cancer Detection and Management• Therapies for Solid Tumors• Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations• The PI3K/Akt/mTOR Pathway The PI3K/Akt/mTOR Pathway• Cancer Vaccines Market Study

Chemistry Reports Bundle - $3595 • Macrocycles• Back-Up Compounds• Fragment Based Drug Discovery• Kinase-Targeted Therapeutics

Drug Delivery Reports Bundle - $4695• Drug Delivery Partnering Terms and Agreements • Drug Delivery Partnering Yearbook 2013 • Advanced Drug Delivery Technologies

Epigenetics, Biomarker, and Cancer Reports Bundle – $4295• Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an

Epigenetic Community Perspective• Commercializing Biomarkers in Therapeutic and Diagnostic Applications• Molecular Biomarkers for Cancer Detection and Management

Epigenetics & Biomarkers Reports Bundle - $3395• Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an

Epigenetic Community Perspective• Commercializing Biomarkers in Therapeutic and Diagnostic Applications

Epigenetics & Cancer Reports Bundle - $3395• Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an

Epigenetic Community Perspective• Molecular Biomarkers for Cancer Detection and Management

IT & Informatics Reports Bundle - $2495 • Advances in Clinical Genome Sequencing and Diagnostics• Next Generation Sequencing Generates Momentum• Cloud Computing Usage in Biotech & Pharma Market Study

Ocular Therapeutics Reports Bundle - $5495• Ocular Disorders: Rising Therapeutics, Technologies, and Devices• EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022 • Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets

PI3K and Kinase Reports Bundle - $1295 • The PI3K/Akt/mTOR Pathway: A Pipeline Analysis • Kinase-Targeted Therapeutics: Development Pipelines, Challenges, and Opportunities

Proteins & Antibody Partnering Terms Bundle - $3795• Antibody Partnering Terms and Agreements • The New Generation of Antibody Therapeutics • Engineering Next-Generation Therapeutic Proteins • Monoclonal Antibodies in the Pipeline: A Segment of Major Growth Report

Vaccines, Cancer Vaccines & Anti-Viral Reports Bundle - $3995• New Trends in Preventive and Therapeutic Vaccines• Vaccine Partnering Terms and Agreements• The Antiviral Pipeline: HIV, HCV, and Influenza

Vaccines & Cancer Vaccines Reports Bundle - $5395• New Trends in Preventive and Therapeutic Vaccines• Vaccine Partnering Terms and Agreements• Cancer Vaccine Partnering Agreements• Cancer Vaccines Market Study

Vaccine Competitor Analysis Reports Bundle - $3695 • New Trends in Preventive and Therapeutic Vaccines• Cancer Vaccines Market Study• The Antiviral Pipeline: HIV, HCV, and Influenza• Competitor Analysis: Herpes Virus Vaccines and Therapeutics• Competitor Analysis: Tuberculosis Vaccines and Therapeutics• Competitor Analysis: CMV Vaccines & Therapeutics • Competitor Analysis: Malaria Vaccines and Therapeutics• Competitor Analysis: Dengue Virus Vaccines and Therapeutics• Competitor Analysis: RSV Vaccines and Therapeutic• Competitor Analysis: Staphylococcus aureus Vaccines• Competitor Analysis: Pseudomonas Aeruginosa Vaccines and Therapeutics

AFFILIATED REPORTSCOLLECTION

Cambridge Healthtech Institute | 250 First Ave, Suite 300, Needham, MA 02494 | T: 781-972-5400 or Toll-free in the U.S. 888-999-6288 | F: 781-972-5425 • www.healthtech.com